ODT and oags DME support for ALP phase III

Ended Awarded Last action

Contract number
75F40123F19011
Awardee
Awarding agency
Obligated
$1,734,967

Award facts

Opportunity
  • 75F40123Q00482 Solicitation number
Contract value 100% obligated
$1,734,967.13 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Labor Hours
Place of performance
Reston, VA 20190, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00008 · ODT and oags DME support for ALP phase III. - the purpose of this modification is to DE-obligate funds and close out the contract. -$1,258
Other Administrative Action P00007 $0
Other Administrative Action P00006 · No cost extension $0
Other Administrative Action P00005 · Add the missing information of contract value increases for modification P00001 and modification of P00002 $0
Change Order P00004 · Redefine and exercise optional item and key personnel change $693,786
Other Administrative Action P00003 $0
Supplemental Agreement for work within scope P00002 · MOD to add 2 sprints to oags' tasks $109,730
Supplemental Agreement for work within scope P00001 · MOD to add 3 sprints to oags' tasks $164,596
Original award $768,113

About this award

This is a $1,734,967.13 federal contract modification awarded by the Food and Drug Administration (FDA), a civilian agency, to ICF Incorporated, L.L.C., a global consulting and technology services firm. The purpose of this modification is to de-obligate funds and close out the contract, which was originally awarded on September 12, 2023 as a Blanket Purchase Agreement (BPA) call with a labor hours pricing type. The contract is not set aside for small businesses and is part of a larger Multiple Award Schedule (MAS) contract vehicle. ICF Incorporated, L.L.C. is a for-profit limited liability company that specializes in providing comprehensive advisory, implementation, and program management services to federal agencies across multiple domains, including climate, energy, transportation, social programs, health, and disaster management.

Quick answers

Who was awarded contract 75F40123F19011?

75F40123F19011 was awarded to ICF Incorporated, L.L.C. by Food and Drug Administration (Department of Health and Human Services) on September 12, 2023.

How much is contract 75F40123F19011 worth?

The government has obligated $1,734,967 on 75F40123F19011.

Is contract 75F40123F19011 an order under another contract?

Yes. 75F40123F19011 is a BPA call under GS35F328DA-75F40120A00042, a blanket purchase agreement, on Multiple Award Schedule (MAS).

Was contract 75F40123F19011 competed?

The extent of competition for 75F40123F19011 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award